Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The gabapentinoids are often recommended as first-line treatments for the management of neuropathic pain. The differing pharmacodynamic and pharmacokinetic profiles can have implications for clinical practice. This article has summarised these key differences. In addition to their use in managing neuropathic pain, gabapentinoids are increasingly being used for off-label conditions despite the lack of evidence. Prescription rates for off-label conditions have overtaken that for on-label use. Similarly, the use of gabapentinoids in the perioperative period is now embedded in clinical practice despite conflicting evidence. This article summarises the risks associated with this increasing use. There is increasing evidence of the potential to cause harm in vulnerable populations such as the elderly and increasing prevalence of abuse. The risk of respiratory depression in combination with opioids is of particular concern in the context of the current opioid crisis. This article describes the practical considerations involved that might help guide appropriate prescribing practices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Chou, R., Gordon, D. B., de Leon-Casasola, O. A., Rosenberg, J. M., Bickler, S., Brennan, T., Carter, T., Cassidy, C. L., Chittenden, E. H., Degenhardt, E., et al. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2015.12.008 · Cited by 3,171 · cited 1×
“70,71 Most reviews demonstrate a reduction in peri-operative opioid consumption after surgery 72–76 but the quality of the trials included is moderate to very low.”
Eroglu, Ç., Allen, N. J., Susman, M. W., O'Rourke, N. A., Park, C. Y., Özkan, E., Chakraborty, C., Mulinyawe, S. B., Annis, D. S., Huberman, A. D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.025 · Cited by 893
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561 · cited 3×
“40,41 These reviews show moderate-quality evidence for pregabalin in postherpetic neuralgia, diabetic neuropathy and low-quality evidence for efficacy in post-stroke pain and after spinal cord injury.”
Schmidt, P. C., Ruchelli, G., Mackey, S. C., & Carroll, I. R. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182a9a896 · Cited by 193 · cited 1×
“69 They are embedded in enhanced recovery pathways, particularly for hip and knee replacement surgery.”
Shanthanna, H., Gilron, I., Rajarathinam, M., AlAmri, R., Kamath, S., Thabane, L., Devereaux, P. J., & Bhandari, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002369 · Cited by 177
Cited by
VX-548 in the treatment of acute pain
Hang Kong, A. Y., Tan, H. S., & Habib, A. S. (2024) · Pain Management · doi:10.1080/17581869.2024.2421749 · Cited by 31
Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
Metadata
- Authors
- Chincholkar, M.
- Venue
- British Journal of Pain
- Publisher
- SAGE Publications
- Published
- 2020-03-13
- Volume
- 14
- Issue
- 2
- Pages
- 104-114
- ISSN
- 2049-4637 (ISSN-L)
- 2049-4645
- OpenAlex
- W3011919203
- Cited by
- 186
- References
- 6
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. https://app.cochat.ai/papers/10.1177/2049463720912496
- The paper
- Chincholkar, M. (2020). Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. British Journal of Pain. https://doi.org/10.1177/2049463720912496
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.